Pfizer to acquire Encysive in $195 million deal
Stephen McGuire
February 20 2008
Pfizer has entered into a deal to acquire publicly-held Houston biotech firm Encysive Pharmaceuticals for $195 million.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.